Ernexa Therapeutics Inc. SEC filings ERNAW
Ernexa Therapeutics Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 3, 2010. Its latest annual report, Form ARS, was filed on May 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3/A | Filing | Mar 24, 2026 | — |
| S-3 | Shelf registration | Mar 16, 2026 | — |
| 424B5 | Prospectus supplement | Feb 10, 2026 | — |
| S-1/A | Amended registration statement | Feb 5, 2026 | — |
| S-1/A | Amended registration statement | Feb 4, 2026 | — |
| S-1 | Registration statement | Feb 3, 2026 | — |
| 424B3 | Prospectus | Jun 18, 2025 | — |
| S-8 | Employee stock plan registration | Jun 11, 2025 | — |
| S-3 | Shelf registration | Jun 11, 2025 | — |
| 424B3 | Prospectus | Apr 29, 2025 | — |
| S-3 | Shelf registration | Apr 16, 2025 | — |
| 424B3 | Prospectus | Nov 18, 2024 | — |
| 424B3 | Prospectus | Nov 18, 2024 | — |
| 424B3 | Prospectus | Nov 18, 2024 | — |
| S-1 | Registration statement | Nov 5, 2024 | — |
| 424B3 | Prospectus | Jan 24, 2024 | — |
| S-8 | Employee stock plan registration | Jan 16, 2024 | — |
| S-3 | Shelf registration | Jan 12, 2024 | — |
| 424B3 | Prospectus | Aug 23, 2023 | — |
| S-3 | Shelf registration | Aug 14, 2023 | — |
| 424B3 | Prospectus | Apr 25, 2023 | — |
| S-1 | Registration statement | Apr 17, 2023 | — |
| 424B3 | Prospectus | Mar 21, 2023 | — |
| POS AM | Filing | Mar 20, 2023 | — |
| 424B3 | Prospectus | May 12, 2022 | — |
| S-3 | Shelf registration | Apr 29, 2022 | — |
| 424B3 | Prospectus | Nov 26, 2021 | — |
| S-1/A | Amended registration statement | Nov 23, 2021 | — |
| S-1 | Registration statement | Nov 18, 2021 | — |
| S-8 | Employee stock plan registration | Oct 12, 2021 | — |
| S-3 | Shelf registration | Aug 13, 2021 | — |
| 424B3 | Prospectus | Jun 4, 2021 | — |
| S-8 | Employee stock plan registration | Jun 3, 2021 | — |
| S-1 | Registration statement | May 27, 2021 | — |
| 424B3 | Prospectus | May 11, 2021 | — |
| S-1 | Registration statement | Apr 30, 2021 | — |
| 424B3 | Prospectus | Feb 8, 2021 | — |
| S-4/A | Filing | Jan 20, 2021 | — |
| S-4/A | Filing | Dec 22, 2020 | — |
| S-4/A | Filing | Nov 25, 2020 | — |
| S-4 | Registration for a merger or exchange | Oct 2, 2020 | — |
| S-8 | Employee stock plan registration | Jun 14, 2019 | — |
| 424B5 | Prospectus supplement | Jun 27, 2018 | — |
| 424B5 | Prospectus supplement | Jun 27, 2018 | — |
| 424B5 | Prospectus supplement | Apr 25, 2017 | — |
| 424B5 | Prospectus supplement | Mar 27, 2017 | — |
| S-3 | Shelf registration | Dec 22, 2016 | — |
| 424B5 | Prospectus supplement | Nov 1, 2016 | — |
| S-8 | Employee stock plan registration | Jun 18, 2015 | — |
| S-8 | Employee stock plan registration | Sep 15, 2014 | — |
| 424B5 | Prospectus supplement | Apr 11, 2014 | — |
| 424B5 | Prospectus supplement | Apr 10, 2014 | — |
| S-3 | Shelf registration | Dec 20, 2013 | — |
| 424B3 | Prospectus | Dec 9, 2013 | — |
| S-3 | Shelf registration | Nov 22, 2013 | — |
| 424B3 | Prospectus | Jan 24, 2012 | — |
| 424B3 | Prospectus | Jan 12, 2012 | — |
| S-3/A | Amendment no. 1 to form s-3 | Jan 6, 2012 | — |
| S-3 | Shelf registration | Dec 20, 2011 | — |
| S-8 | Employee stock plan registration | Jun 4, 2010 | — |
Showing 60 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ERNA (Nasdaq), ERNAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 748592
- Former names
- Eterna Therapeutics Inc. (until Apr 4, 2025); Brooklyn ImmunoTherapeutics, Inc. (until Oct 14, 2022); NTN BUZZTIME INC (until Mar 23, 2021); NTN COMMUNICATIONS INC (until Dec 20, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.